MKI67 and breast carcinoma: SHAP identified SP_DL3 signature as the top contributor in both MP_GBDT and CMP_GBDT models.<h4>Conclusions</h4>The MP_GBDT model accurately and non-invasively predicted Ki-67 expression in breast cancer, with SP_DL3 signature being the main contributor.